![]() ![]() The study design is open-label in which neither investigator nor study participants will be blinded to study treatment. After 16-weeks, participants initially assigned to DSME alone will cross-over to receive the intervention FGM device, while those initially randomized to using a FGM will continue using their device for an additional 16 weeks (Phase 2). Both Dexcom G6 CGM and Freestyle Libre 2 Flash Glucose Monitoring System can measure glucose levels continuously and translate the readings into data on your. DSME sessions for both groups will consist of four individual in-clinic sessions and two telephone sessions. ![]() Participants randomized to the Control arm will receive 6 DSME sessions matched to time and location of the Intervention group. Participants randomized to the Intervention arm will receive a FreeStyle Libre FGM System, 1 training session on its proper use, and 6 DSME sessions. Abbotts Freestyle Libre Libre is a Flash glucose monitoring system (may also be referred to as isCGM or intermittent scanning CGM in articles). In Phase 1, participants will be randomized at a 1:1 ratio, stratified by use of glucagon-like peptide-1 receptor agonist to receive either a flash glucose monitor (FGM) + diabetes self-management education (DSME) (Intervention arm) or to DSME alone (Control arm). The IMMEDIATE study is a two-phased, cross-over study. Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Why Should I Register and Submit Results?. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |